Atlas Trials

Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy

Clinical trial NCT06583343 · COMPLETED

Trial details

NCT number
NCT06583343
Sponsor
Gaziosmanpasa Research and Education Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cerebral Palsy Spastic Diplegia
Start date
2022-08-25
Primary completion
2023-05-25
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.